Highland Life Sciences

Lasne ·KBO/BCE: BE 0760.496.727

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	31-07-2025	on the day	2025-00343297
31-12-2023	31-07-2024	09-08-2024	9 d late	2024-00339974
31-12-2022	31-07-2023	26-07-2023	5 d early	2023-00279835
31-12-2021	31-07-2022	13-07-2022	18 d early	2022-20201382

Metric	This company	Sector median	Position in the sector
Solvency	51.1%	60.6%	better than 41% of 12464 sector peers
Net result	€137k	€31k	better than 93% of 12466 sector peers
Equity	€379k	€63k	better than 94% of 12472 sector peers
Gross operating margin	€200k	€52k	better than 93% of 12452 sector peers
Total assets	€742k	€124k	better than 92% of 12465 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€742k
Fixed assets	21/28	€3k
Tangible fixed assets	22/27	€3k
Current assets	29/58	€738k
Amounts receivable within one year	40/41	€46k
Investments	50/53	€615k
Cash & bank	54/58	€77k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€742k
Equity	10/15	€379k
Contributions / capital	10/11	€2k
Reserves	13	€368k
Accumulated profits (losses)	14	€9k
Amounts payable	17/49	€363k
Amounts payable within one year	42/48	€363k
Trade debts payable within one year	44	€6k
Income statement
Gross operating margin	9900	€200k
Operating result	9901	€199k
Financial income	75	€4k
Financial charges	65	€68
Result before taxes	9903	€203k
Income taxes	67/77	€66k
Net result for the period	9904	€137k
Result to be appropriated	9905	€137k

Summary